Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake

被引:4
|
作者
Huff, Courtney [1 ]
Bhide, Nirmal [1 ]
Schroering, Allen [2 ]
Yamamoto, Bryan K. [2 ]
Gudelsky, Gary A. [1 ]
机构
[1] Univ Cincinnati, James Winkle Coll Pharm, Cincinnati, OH 45221 USA
[2] Univ Toledo, Coll Med, Dept Neurosci, Toledo, OH 43606 USA
关键词
MDMA; Serotonin; Serotonin transporter; CELL-SURFACE EXPRESSION; RAT-BRAIN; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; SEROTONIN TRANSPORTER; NITRIC-OXIDE; NEUROTOXICITY; DEPLETION; ECSTASY; PROTEIN; METHYLENEDIOXYMETHAMPHETAMINE;
D O I
10.1016/j.brainresbull.2013.01.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent studies have demonstrated that a preconditioning regimen (i.e., repeated low doses) of MDMA provides protection against the reductions in tissue concentrations of 5-HT and 5-HT transporter (SERT) density and/or expression produced by a subsequent binge regimen of MDMA. In the present study, the effects of preconditioning and binge treatment regimens of MDMA on SERT function were assessed by synaptosomal 5-HT uptake. Synaptosomal 5-HT uptake was reduced by 72% 7 days following the binge regimen (10 mg/kg, i.p. every 2 h for a total of 4 injections). In rats exposed to the preconditioning regimen of MDMA (daily treatment with 10 mg/kg for 4 days), the reduction in synaptosomal 5-HT uptake induced by a subsequent binge regimen was significantly less. Treatment with the preconditioning regimen alone resulted in a transient 46% reduction in 5-HT uptake that was evident 1 day, but not 7 days, following the last injection of MDMA. Furthermore, the preconditioning regimen of MDMA did not alter tissue concentrations of 5-HT, whereas the binge regimen of MDMA resulted in a long-term reduction of 40% of tissue 5-HT concentrations. The distribution of SERT immunoreactivity (ir) in membrane and endosomal fractions of the hippocampus also was evaluated following the preconditioning regimen of MDMA. There was no significant difference in the relative distribution of SERTir between these two compartments in control and preconditioned rats. The results demonstrate that SERT function is transiently reduced in response to a preconditioning regimen of MDMA, while long-term reductions in SERT function occur in response to a binge regimen of MDMA. Moreover, a preconditioning regimen of MDMA provides protection against the long-term reductions in SERT function evoked by a subsequent binge regimen of the drug. It is tempting to speculate that the neuroprotective effect of MDMA preconditioning results from a transient down-regulation in SERT function. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [11] MDMA as a model of 5-HT dysfunction
    Corradetti, R
    Bagdy, G
    Kelly, PAT
    Olverman, HJ
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S356 - S356
  • [12] Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT)
    Bryan-Lluka, LJ
    Papacostas, MH
    Paczkowski, FA
    Wanstall, JC
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (01) : 63 - 70
  • [13] Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis
    Moret, C
    Briley, M
    JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (2-3) : 147 - 160
  • [14] Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis
    C. Moret
    M. Briley
    Journal of Neural Transmission, 1997, 104 : 147 - 160
  • [15] Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brain
    Gobbi, M
    Bergami, A
    Caltavuturo, C
    DallaValle, F
    Mennini, T
    Caccia, S
    NEUROSCIENCE LETTERS, 1996, 219 (01) : 5 - 8
  • [16] IFOXETINE - AN UNUSUAL 5-HT UPTAKE INHIBITOR OR AN INHIBITOR OF 5-HT RELEASE
    WALDMEIER, PC
    BAUMANN, PA
    PHARMACOPSYCHIATRY, 1986, 19 (04) : 318 - 319
  • [17] THE REPEATED BLOCKADE OF THE 5-HT TRANSPORTER ENHANCES EXTRACELLULAR 5-HT IN CORTEX BUT NOT IN RAPHE NUCLEI - IMPLICATIONS FOR ANTIDEPRESSANT TREATMENT
    BEL, N
    ARTIGAS, F
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 : S92 - S92
  • [18] The recovery of 5-HT transporter and 5-HT immunoreactivity in injured rat spinal cord
    Yasuo Saruhashi
    Yoshitaka Matsusue
    Mineko Fujimiya
    Archives of Orthopaedic and Trauma Surgery, 2009, 129
  • [19] The recovery of 5-HT transporter and 5-HT immunoreactivity in injured rat spinal cord
    Saruhashi, Yasuo
    Matsusue, Yoshitaka
    Fujimiya, Mineko
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2009, 129 (09) : 1279 - 1285
  • [20] Platelet 5-HT uptake, basal 5-HT and CSF 5-HIAA in epilepsy
    Shukla, R
    Satyavrat
    Nag, D
    Verma, M
    Shanker, K
    ASIA PACIFIC JOURNAL OF PHARMACOLOGY, 1996, 11 (3-4): : 103 - 107